title: [Effectiveness and risks related to enteric decolonization with oral streptomycin for glycopeptide-resistant enterocci carriers].
authors.forename: V
authors.initials: V
authors.lastname: Gendrin
authors.forename: S
authors.initials: S
authors.lastname: Hénard
authors.forename: M
authors.initials: M
authors.lastname: Petitfrère
authors.forename: T
authors.initials: T
authors.lastname: May
authors.forename: C
authors.initials: C
authors.lastname: Rabaud
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D024881:Drug Resistance, Bacterial; D016984:Enterococcus faecium / Q000187:drug effects*; D005260:Female; D006020:Glycopeptides / Q000494:pharmacology*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007422:Intestines / Q000382:microbiology; D008297:Male; D012307:Risk Factors; D013307:Streptomycin / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D013307:Streptomycin